The neural mechanisms underlying cholinergic cell death within the basal forebrain

International Journal of Developmental Neuroscience

Volumn 16, Issue 7-8, 1998, Pages 729-735

  Wenk, Gary L ^a   Willard, Lauren B ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CYTOKINE; N METHYL DEXTRO ASPARTIC ACID;

ARTICLE; CELL DEATH; CHOLINERGIC NERVE CELL; CHOLINERGIC STIMULATION; CHOLINERGIC SYSTEM; FOREBRAIN; INFLAMMATION; MAGNOCELLULAR NUCLEUS; MITOCHONDRIAL RESPIRATION; NERVE CELL DEGENERATION; PRIORITY JOURNAL;

ACETYLCHOLINE; ANIMALS; CELL DEATH; HUMANS; MITOCHONDRIA; NEURITIS; NEURONS; PROSENCEPHALON; SUBSTANTIA INNOMINATA;

EID: 0032463256     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-5748(98)00081-1     Document Type: Article

References (97)

1. Aisen, P. S. and Davis, K. L., Inflammatory mechanisms in Alzheimer's disease: implications for therapy. Am. J. Psychiat., 1994, 151, 1105-1113.
2. Albin, R. L. and Greenamyre, J. T., Alternative excitotoxic hypotheses. Neurol., 1992, 42, 733-738.
3. Araki, M., McGeer, P. L. and McGeer, E. G., Differential effect of kainic acid on somatostatin, gabaergic and cholinergic neurons in the rat striatum. Neurosci. Lett., 1985, 53, 197-202.
4. Beal, M. F., Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann. Neurol., 1992, 31, 119-130.
5. Beal, M. F., Aging, energy, and oxidative stress in neurodegenerative diseases. Ann. Neurol., 1995, 38, 357-366.
6. Beal, M. F., Kowall, N. W., Swartz, K. J., Ferrante, R. J. and Martin, J. B., Differential sparing of somatostatin-neuropeptide Y and cholinergic neurons following striatal excitotoxin lesions. Synapse, 1989, 3, 38-47.
7. Bluthe R. -M., Dantzer, R. and Kelley, K. W., Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in rat. Brain Res., 1992, 573, 318-320.
8. Bredt, D. S. and Snyder, S. H., Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. Natl. Acad. Sci. U.S.A., 1989, 86, 9030-9033.
9. Breitner, J. C., Gav, B. A., Welsh, K. A., Plassman, B. L., McDonald, W. M. and Helms, M. J., Inverse association of anti-inflammatory treatments and Alzheimer's disease : initial results of a co-twin control study. Neurol., 1994, 44, 227-232.
10. Bridges, R. J., Koh, J. Y., Hatalski, C. G. and Cotman, C. W., Increased excitotoxic vulnerability of cortical cultures with reduced levels of glutathione. Eur. J. Pharmacol., 1991, 192, 199-200.
11. Brugg, B., Dubreuil, Y. L., Huber, G., Wollman, E. E., Delhaye-Bouchaud, N. and Mariani, J., Inflammatory processes induce β-amyloid precursor protein changes in mouse brain. Proc. Natl. Acad. Sci. U.S.A., 92, 3032-3035.
12. Cashman, N. R. and Antel, J. P., Amytrophic lateral sclerosis : an immunologic perspective. Immunol. Allergy Clin. N. Am., 1986, 13, 303-308.
13. Choi, D. W., Ionic dependence of glutamate neurotoxicity. J. Neurosci., 7, 1987, 369-379.
14. Choi, D. W., Koh, J. and Peters, S., Pharmacology of glutamate neurotoxicity in cortical cell culture : attenuation by NMDA antagonists. J. Neurosci., 1988, 8, 185-196.
15. Coyle, J. T., Price, D. L. and DeLong, M. R., Alzheimer's disease : a disorder of cortical cholinergic innervation. Science, 1983, 219, 1184-1190.
16. Coyle, J. T. and Schwarcz, R., The use of excitatory amino acids as selective neurotoxins. In Handbook of Chemical Neuro anatomy., Vol. 1, Methods in Chemical Neuroanatomy, ed. A. Bjorklund, and T. Hokfelt. Elsevier Science Publishers, New York, 1983, pp. 508-527.
17. Danysz, W., Parson, C. G., Karcz-Kubicha, M., Lazarewicz, J. and Wenk, G., Novel systemically active antagonists of the glycine site of NMDA receptor-behavioral characterisation. Pharmacol. Toxicol., 1997, 80, 17-20.
18. Danysz, W., Parsons, C. G., Kornhuber, J., Schmidt, W. J., and Quack, G., Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents - preclinical studies. Neurosci. Biobehav. Rev., 1997, 21, 455-468.
19. Dawson, V. L., Dawson, T. M., London, E. D., Bredt, D. S., and Snyder, S. H., Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. U.S.A., 1991, 88, 6368-6371.
20. Dunnett, S.B., Whishaw, I. Q., Jones, G. H. and Bunch, S. T., Behavioral, biochemical and histochemical effects of different neurotoxic amino acids injected into nucleus basalis magnocellularis of rats. Neurosci., 1987, 20, 653-669.
21. Farooqui, A. A. and Horrocks, L. A., Excitatory amino acid receptors, neural membrane phospholipid metabolism and neurological disorders. Brain Res. Rev., 1991, 16, 1-191.
22. Finn, S. F., Swartz, K. J. and Beal, M. F., 2-Chloroadenosine attenuates NMDA, kainate, and quisqualate toxicity. Neurosci. Lett., 1991, 126, 191-194.
23. Foley, P., Bradford, H. F., Dochart, M., Fillet, H., Luine, V. N., McEwen, B., Buch, G., Winblad, B. and Hardy, J., Evidence for the presence of antibodies to cholinergic neurons in the serum of patients with Alzheimer disease. J. Neurol., 1988, 235, 466-471.
24. Frandsen, A., Anderson, C. F. and Schousboe, A., Possible role of cGMP in excitatory amino acid induced cytotoxicity in cultured cerebral cortical neurons. Neurochem. Res., 1991, 17, 35-43.
25. Frederickson, R. C. A. and Brunden, K. R., New opportunities in AD research : roles of immunoinflammatory responses and glia. Alz. Dis. Assoc. Dis., 1994, 8, 159-165.
26. 2+ of N-methyl-D-aspartate and quisqualate neurotoxicity in young rat hippocampal slices. Neurosci. Lett., 1989, 7, 316-322.
27. Garthwaite, G. and Garthwaite, J., AMPA neurotoxicity in rat cerebellar and hippocampal slices : histological evidence for three mechanisms. Eur. J. Neurosci., 1991, 3, 715-728.
28. Garthwaite, G., Williams, G. D. and Garthwaite, J., Glutamate toxicity: an experimental and theoretical analysis. Eur. J. Neurosci., 1992, 4, 353-360.
29. Giulian, D., Haverkamp, L. J., Li, J., Karshin, W. L., Yu, J., Tom, D., Li, X. and Kirkpatrick, J. B., Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain. Neurochem. Int., 1995, 27, 119-137.
30. Goldgaber D., Harris H. W., Hla T., Maciag T., Donnelly R. J., Jacobsen J. S., Vitek M. P. and Gajdusek D.C., Interleukin-1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelia cells. Proc. Natl. Acad. Sci. U.S.A., 1989, 86, 7606-7610.
31. Griffin, W. S. T., Sheng, J. G., Gentleman, S. M., Graham, D. I., Mrak, R. E. and Roberts, G. W., Microglial interleukin-1α expression in human head injury : correlations with neuronal and neuritic B-amyloid precursor protein expression. Neurosci. Lett., 1994, 176, 133-136.
32. Griffin, W. S. T., Stanley, L. C., Ling, C., White, L., MacLeod, V., Perrot, L. J., White, C. L. and Arora, C., Brain interleukin-1 and S-100 immunoreactivity are elevated in Down Syndrome and Alzheimer disease. Proc. Natl. Acad. Sci., U.S.A., 1989, 86, 7611-7615.
33. Harrington, C. A. and Wenk, G. L., Differential vulnerability of basal forebrain cholinergic and NADPH-diaphorase cells. Psychobio., 1992, 20, 254-260.
34. Hassel, B. and Sonnewald, U., Selective inhibition of the tricarboxylic acid cycle of GABAergic neurons with 3-nitroproprionic acid in vivo. J. Neurochem., 1995, 65, 1184-1191.
35. Huettner, J. E. and Bean, B. P., Block of N-methyl-D-aspartate activated current by the anticonvulsant MK-801 ; selective binding to open channels. Proc. Natl. Acad. Sci. U.S.A., 1988, 85, 1307-1311.
36. Hunot, S., Brugg, B., Ricard, D., Michel, P. P., Muriel, M. P., Ruber, M., Faucheux, B. A., Agid, Y. and Hirsch, E. C., Nuclear translocation of NF-6B is increased in dopaminergic neurons of patients with Parkinson disease. Proc. Natl. Acad. Sci. U.S.A., 1997, 94, 7531-7536.
37. Kálmán, J., Engelhardt, J. I., Le, W. D., Xie, W., Kovacs, I., Kása, P. and Appel, S. H., Experimental immune-mediated damage of septal cholinergic neurons. J. Neuroimmunol., 1997, 77, 63-77.
38. 2 in rat astrocyte cultures: modulatory effect of neuropeptides. Endocrinol., 1989, 124, 3125-3127.
39. Kiedrowski, L., Costa, E. and Wroblewski, J. T., Glutamate receptor agonists stimulate nitric oxide synthase in primary cultures of cerebellar granule cells. J. Neurochem., 1992, 58, 335-341.
40. Koh, J.Y. and Choi, D. W., Vulnerability of cultured cortical neurons to damage by excitotoxins : differential susceptibility of neurons containing NADPH-diaphorase. J. Neurosci., 1988, 8, 2153-2163.
41. Koh, J., Palmer, E. and Cotman, C. W., Activation of the metabotropic glutamate receptor attenuates N-methyl-D-aspartate neurotoxicity in cortical cultures. Proc. Natl. Acad. Sci. U.S.A., 1991, 88, 9431-9435.
42. Koh, J., Palmer, E., Lin, A. and Cotman, C. W., A metabotropic glutamate receptor agonist does not mediate neuronal degeneration in cortical culture. Brain Res., 1991, 561, 338-343.
43. Majdan, M., Lachance, C., Gloster, A., Aloyz, R., Zeindler, C., Bamji, S., Bhakar, A., Belliveau, D., Fawcett, J., Miller, F. D. and Barker, P. A., Transgenic mice expressing the intracellular domain of the p75 neurotrophin receptor undergo neuronal apoptosis. J. Neurosci., 1997, 17, 6988-6998.
44. Martinez, M., Frank, A. and Heranz, A., Relationship of interleukin-1β and B2-microglobulin with peptides in cerebrospinal fluid of patients with dementia of the Alzheimer type. J. Neuroimmol., 1993, 48, 235-240.
45. McGeer, P. L., Akiyama, H., Itagaki, S. and McGeer, E. G., Immune system response in Alzheimer's disease. Can. J. Neurol. Sci., 1989, 16, 516-527.
46. McGeer, P. L., McGeer, E. G., Suzuki, J., Dolman, C. E. and Nagai, T., Aging, Alzheimer's disease and the cholinergic system of the basal forebrain. Neurol., 1984, 34, 741-745.
47. Mesulam, M.-M., Mufson, E. J., Levey, A. I. and Wainer, B. H., Cholinergic innervation of cortex by the basal forebrain : cytochemistry and cortical connections of the septal area diagonal band nuclei, nucleus basalis (substantia innominata) and hypothalamus in the rhesus monkeys. J. Comp. Neurol., 1983, 214, 170-197.
48. Morgan, B. P., Complement : Clinical Aspects and Relevance to Disease. Academic Press, San Diego, CA, 1990, pp. 215-225.
49. Mrak, R. E., Sheng, J. G. and Griffin, W. S. T., Glial cytokines in Alzheimer's disease : review and pathogenic implications. Human Pathol., 1995, 26, 816-823.
50. Murphy, T. H., Miyamoto, M., Sastre, A., Schnaar, R. L. and Coyle, J. T., Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron, 1989, 2, 1547-1558.
51. Murphy, T. H., Schnaar, R. L. and Coyle, J. T., Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake. FASEB, 1990, 4, 1624-1633.
52. Nadler, J. V., Evenson, D. A. and Cuthbertson, G. J., Comparative toxicity of kainic acid and other acidic amino acids toward rat hippocampal neurons. Neurosci., 1981, 6, 2505-2517.
53. Novelli, A., Reilly, J. A., Lysko, P. G. and Henneberry R. C., Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res., 1988, 451, 205-212.
54. Olney, J. W., de Gubareff, T. and Labruyere, J., Seizure-related brain damage induced by cholinergic agents. Nature, 1983, 301, 520-522.
55. Page, K. J., Everitt, B. J., Robbins, T. W., Marston, H. M. and Wilkinson, L. S., Dissociable effects on spatial maze and passive avoidance acquisition and retention following ampa- and ibotenic acid-induced excitotoxic lesions of the basal forebrain in rats : differential dependence on cholinergic neuronal loss. Neurosci., 1991, 43, 457-472.
56. Pasqualotto, B.A. and Vincent, S. R., Galanin and NADPH-diaphorase coexistence in cholinergic neurons of the rat basal forebrain. Brain Res., 1991, 551, 78-86.
57. Perkins, M. N. and Stone, T. W., Quinolinic acid : regional variations in neuronal sensitivity. Brain Res., 1983, 259, 172-176.
58. Peters, S., Koh, J. and Choi, D. W., Zinc selectivity blocks the action of N-methyl-D-aspartate on cortical neurons. Science, 1987, 236, 589-593.
59. Piredda, S. and Gale, K., Role of excitatory amino acid transmission in the genesis of seizures elicited from the deep prepiriform cortex. Brain Res, 1986, 377, 205-210.
60. Quan, N., Sundar, S. K. and Weiss, J. M., Induction of interleukin-1 in various brain regions after peripheral and central injections of lipopolysaccharide. J. Neuroimmunol., 1994, 49, 125-134.
61. Rasmusson, D. X., Brandt, J., Martin, D. B. and Folstein, M. F., Head injury as a risk factor in Alzheimer's disease. Brain Inj., 1995, 9, 213-219.
62. Raulli, R. and Wroblewski, J. T., Stimulation of phosphoinositol hydrolysis by ibotenic acid in cerebellar neurons via two glutamate receptor subtypes. Drug Dev. Res., 1991, 24, 375-384.
63. Robbins, T. W., Everitt, B. J., Marston, H. M., Wilkinson, J., Jones, G. H. and Page, K. J., Comparative effects of ibotenic acid- and quisqualic acid-induced lesions of the substantia innominata on attentional function in the rat : further implications for the role of the cholinergic neurons of the nucleus basalis in cognitive processes. Behav. Brain Res., 1989, 35, 221-240.
64. Rogers, J., Cooper, N., Webster, S., Schultz, J., McGeer, P. L., Styren, S. D., Civin, W. H., Brachova, L., Bradt, B., Ward, P. and Lieberburg, I., Complement activation by β-amyloid in Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A., 1992, 89, 10,016-10,020.
65. Rogers, J., Kirby, L. C., Hempelman, S. R., Berry, D. L., McGeer, P. L., Kaszniak, A. W., Zalinski, J., Cofield, M., Mansukhani, L., Wilson, P. and Kogan, F., Clinical trials of indomethacin in Alzheimer's disease. Neurol., 1993, 43, 1609-1611.
66. Rothman, S. M. and Olney, J. W., Excitotoxicity and the NMDA receptor. TINS, 1987, 10, 299-302.
67. Savolainen, K. M. and Hirvonen, M. R., Second messengers in cholinergic-induced convulsions and neuronal injury. Toxicol. Lett., 1992, 64/65, 437-445.
68. Savolainen, K., Hirvonen, M. R. and Naarala, J., Phosphoinositide second messengers in cholinergic excitotoxicity. Neuro Toxicol., 1994, 15, 493-502.
69. Schapira, A. H. V. and Cooper, J. M., Mitochondrial function in neurodegeneration and ageing. Mutation Res., 1992, 275, 133-143.
70. Schwarcz, R. and Kohler, C., Differential vulnerability of central neurons of the rat to quinolinic acid. Neurosci. Lett., 1983, 38, 85-90.
71. Selmaj, K. W. and Raine C. S., Tumor necrosis factor mediates mylein and oligodendrocyte damage in vitro. Ann. Neurol., 1988, 23, 339-346.
72. Sheng, J. G., Ito, K., Skinner, R. D., Mrak, R. E., Rovnaghi, C. R., Van Eldik, L. J. and Griffin, S. T., In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiol. Aging, 1996, 17, 761-766.
73. Siliprandi, R., Lipartiti, M., Fadda, E., Sautter, J. and Manev, H., Activation of the glutamate metabotropic receptor protects retina against N-methyl-D-aspartate toxicity. Eur. J. Pharmacol., 1992, 219, 173-174.
74. Skaper, S. D., Facci, L. and Leon, A., Inflammatory mediator stimulation of astrocytes and meningeal fibroblasts induces neuronal degeneration via the nitridergic pathway. J. Neurochem., 1995, 64, 266-276.
75. Swierkosz, T.A., Mitchell, J.A., Warner, T. D., Botting, R. M. and Vane, J. R., Co-induction of nitric oxide synthase and cyclo-oxygenase : interactions between nitric oxide and prostanoids. Br. J. Pharmacol., 1995, 114, 1335-1342.
76. Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R. and Verman, I. M., Suppression of TNF-∀-induced apoptosis by NF-6B. Science, 1996, 274, 787-789.
77. Van der Zee, C. E. E. M., Ross, G. M., Riopelle, R. J. and Hagg, T., Survival of cholinergic forebrain neurons in developing p75 deficient mice. Science, 1995, 274, 1729-1732.
78. Vincent, S. R. and Hope, B. T., Neurons that say NO. TINS, 1992, 15, 108-113.
79. Vincent, S. R., Johansson, O., Hokfelt, T., Skirboll, L., Eide, R. P., Terenius, L., Kimmel, J. and Goldstein, M., NADPH-diaphorase : a selective histochemical marker for striatal neurons containing both somatostatin- and avian pancreatic polypeptide (APP)-like immunoreactivities. J. Comp. Neurol., 1983, 217, 252-263.
80. Vincent, S. R. and Kimura, H., Histochemical mapping of nitric oxide synthase in the rat brain. Neurosci., 1992, 46, 755-784.
81. Vogels, O. J. M., Broere, C. A. J., Ter Laak, H. J., Ten Donkelaar, H. J., Nieuwenhys, R. and Schulte, B. P. M., Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer = s disease. Neurobiol. Aging, 1990, 11, 3-13.
82. Waldvogel, H. J., Faull, R. L. M., Williams, M. N. and Dragunow, M., Differential sensitivity of calbindin and parvalbumin immunoreactive cells in the striatum to excitotoxins. Brain Res., 1991, 546, 329-335.
83. Wendenfeld, J., Kahbha, K., Reches, A. and Shohami, E., Role of the central adrenergic system in the regulation of prostaglandin biosynthesis in rat brain. J. Neurochem., 1991, 58, 694-699.
84. Wenk, G. L., Cysteine protects basal forebrain cholinergic neurons from ibotenic, but not quisqualic, acid. Soc. Neurosci. Abst., 1989, 15, 768.
85. B antagonists show neuroprotective activity in vivo. Amino Acids, 1998, 14, 223-226.
86. Wenk, G. L., Danysz, W. and Mobley, S. L., Investigations of neurotoxicity and neuroprotection within the nucleus basalis of the rat. Brain Res., 1994, 655, 7-11.
87. Wenk, G. L., Danysz, W. and Mobley, S. L., MK-801, memantine and amantadine show potent neuroprotective activity against NMDA toxicity in the NBM: a dose response study. Eur. J. Pharmacol., 1995, 293, 267-270.
88. Wenk, G. L., Danysz, W. and Roice, D. D., The effects of mitochondrial failure upon cholinergic and glutamatergic toxicity within the nucleus basalis. NeuroRep., 1996, 7, 1453-1456.
89. Wenk, G. L., Harrington, C.A., Tucker, D.A., Rance, N. E. and Walker, L. C., Basal forebrain neurons and memory: a biochemical, histological and behavioral study of differential vulnerability to ibotenate and quisqualate. Behav. Neurosci., 1992, 106, 909-923.
90. Wenk, G. L., Zajaczkowski, W. and Danysz, W., Neuroprotection of acetylcholinergic basal forebrain neurons by memantine and neurokinin B. Behav. Brain Res., 1997, 83, 129-133.
91. Wenk, H., Bigl, V. and Meyer, U., Cholinergic projections from magnocellular nuclei of the basal forebrain to cortical areas in rats. Brain Res. Rev., 1980, 2, 295-316.
92. 2+ antagonize NMDA and GABA responses of hippocampal neurons. Nature, 1987, 328, 640-643.
93. Willard, L.B., Hauss-Wegrzyniak, B. and Wenk, G. L., The pathological and biochemical consequences of acute and chronic neuroinflammation within the basal forebrain of rats. Neurosci. (in press).
94. Yeh, G-C., Bonhaus, D. W. and McNamara, J. O., Evidence that zinc inhibits TV-methyl-D-aspartate receptor-gated ion channel activation by noncompetitive antagonism of glycine binding. Mol. Pharmacol., 1990, 38, 14-19.
95. Yeung M. C., Pulliam L. and Lau A. S., The HIV envelope protein gp120 is toxic to human brain-cell cultures through the induction of interleukin-6 and tumor necrosis factor-alpha. AIDS, 1995, 9, 137-143.
96. Zajicek, J. P., Wing, M., Scolding, N. J. and Compston, D. A. S., Interactions between oligodendrocytes and microglia: a major role for complement and tumor necrosis factor in oligodendrocyte adherence and killing. Brain, 1992, 115, 1611-1631.
97. Zeevalk, G. D. and Nicklas, W. J., Mechanisms underlying initiation of excitotoxicity associated with metabolic inhibition. J. Pharmacol. Exp. Ther., 1990, 253, 1285-1292.